General Information of This Metabolic Reaction (MR) (ID: MR002345)
Formula Reactant AGN 190832 Product AGN 190844
Reactant Info Product Info
Metabolic Type Hydrolysis - Hydrolysis
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002349 Tazarotene AGN 190832 Oxidation - Oxidation Tazarotene [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002346 AGN 190832 AGN 190833 Oxidation - Oxidation Tazarotene [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002343 Tazarotenic acid AGN 190844 Oxidation - Oxidation Tazarotene [1], [2], [3]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002344 AGN 190844 AGN 190843 Oxidation - Oxidation Tazarotene [1]
References
1 Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis Clin Pharmacokinet. 1999 Oct;37(4):273-87. doi: 10.2165/00003088-199937040-00001.
2 Cytochrome P450 2C8 and flavin-containing monooxygenases are involved in the metabolism of tazarotenic acid in humans. Drug Metab Dispos. 2003 Apr;31(4):476-81.
3 LABEL:AZAROTENE aerosol, foam

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.